WebLeaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA … http://pharmabiz.com/NewsDetails.aspx?aid=157525&sid=2

Sysmex Inostics

WebPlease contact the Sysmex office in your region. General Inquiries US: 1-800-3SYSMEX 1-800-379-7639 or 1-847-367-3500 Canada: 905-336-7900 Email us [email protected] Media Inquiries Sysmex Media Relations [email protected] 224-543-9500 Web4 hours ago · Sysmex Inostics, Inc., a subsidiary of Japan’s Sysmex Corporation, is a Baltimore-based biotechnology firm and CLIA-certified lab offering biomarker testing to accelerate the development of personalized medicine. Genomic Testing Cooperative (GTC) is a privately-owned molecular testing company located in Irvine, California. The company ... flexalight

Sysmex Inostics, GTC partner to accelerate therapeutic discovery …

Web2 days ago · BALTIMORE and IRVINE, Calif. , April 13, 2024 /PRNewswire/ -- Sysmex Inostics Inc., a subsidiary of Japan's Sysmex Corporation and Baltimore -based biotechnology firm, and Genomic Testing Cooperative (GTC), based in Irvine, California , formed a strategic partnership for Sysmex Inostics to commercialize GTC's tissue and liquid biopsy solid … WebOct 20, 2024 · New Tool for Detection of Minimal Residual Disease in Acute Myeloid Leukemia to Better Help in Fight Against Cancer. BALTIMORE, Oct. 20, 2024 /PRNewswire/ -- Sysmex Inostics has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML). A global leader and … WebJan 26, 2024 · Sysmex Inostics, Inc., a US-based Sysmex Corporation subsidiary, empowers discoveries in oncology by providing investigators with ultra-sensitive, quantitative, and cost-effective CLIA-validated ... flex a light website